Market Analysis of Tetracycline And Chloramphenicol
Doxycycline hydrochloride, the transaction price is close to 500. After a slight buffer in the past two weeks, the price continued to fall, and the market quotation was 510-528, a year-on-year decrease of 16.5%. It can be seen that the current demand factors dominate. The average prices for the same period in 2019, 2020, and 2021 were 360, 670, and 630, respectively. The same period in 2019 was in the era of priceless and out of stock, and it was from then on that the road to doxycycline hydrochloride was opened, and all the way Rising, breaking through the 600 mark at the end of the year, and breaking through the 700 mark in August 2020, maintaining a two-year highlight. This year, the transaction price continued to decline due to demand. The 4th era is just around the corner, and we will pay attention to it together.
Oxytetracycline and oxytetracycline hydrochloride run strongly. Oxytetracycline is a fermented product. Affected by rising grain prices, the price has risen slightly. The transaction price of oxytetracycline is above 85. Oxytetracycline hydrochloride transaction price 105-109
Chlortetracycline hydrochloride, running weakly, the market price is around 202
The price of florfenicol continues to decline, and the market quotation range is 430-450, which is a new low for 16 consecutive months, and the price is the same as that at the end of 2020. The supply of various brands in the market is sufficient, the impact of demand weakens, and the downward speed is fast, and the transaction is based on actual Demand is the main. The "5++" era that has lasted for more than a year may be difficult to recover in the short term.
Looking for chemical products? Let suppliers reach out to you!
2026-07-04
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
Analysis of The Domestic Tetracycline And Chloramphenicol Market in The 17th Week of 2022
-
Analysis of The Domestic Tetracycline And Chloramphenicol Market in The 17th Week of 2022
-
Market Analysis of Tetracycline and Chloramphenicol in Week 16
-
Market Analysis of Tetracycline and Chloramphenicol in Week 16
-
Market Analysis of Tetracycline and Chloramphenicol Raw Materials
-
Market Analysis of Tetracycline and Chloramphenicol Raw Materials
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
Recommend Reading
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
McKinsey Pays to Close a Purdue Liability Chapter
-
India’s API Trade Balance Turns Positive
-
BioNTech’s Founders Turn the Page
-
Novo Nordisk Faces a Compliance Test
-
Traditional Peak Season Arrives, Palm Oil Prices Expected to Rise in China
-
Global Chemical Exports Are Freezing in 2026
-
Premium Global Chemical Sourcing Requests (3-7 Jan, 2026)
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
BASF's Zhanjiang Plant Steam Cracking Unit Commences Operation